Archives for: February 3rd, 2020

CORMEDIX APPROVED TO SELL $5.5 MILLION OF NOL TAX BENEFITS THROUGH THE NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY PROGRAM

Written by Sam Nelson on February 3, 2020

Berkeley Heights, NJ – February 3, 2020 – CorMedix Inc….

CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application

Written by Sam Nelson on February 3, 2020

Berkeley Heights, NJ — February 3, 2020 — CorMedix Inc….